-
Mashup Score: 5
Patients with COPD and type 2 diabetes had a reduced risk for COPD hospitalization, noninvasive positive-pressure ventilation and all-cause mortality if they used an SGLT-2 inhibitor, according to study results.These data were published in Annals of the American Thoracic Society.
Source: www.healio.comCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 5
Patients with COPD and type 2 diabetes had a reduced risk for COPD hospitalization, noninvasive positive-pressure ventilation and all-cause mortality if they used an SGLT-2 inhibitor, according to study results.These data were published in Annals of the American Thoracic Society.
Source: www.healio.comCategories: General Medicine News, PulmonologyTweet-
Published in @AnnalsATS: Patients with #COPD and type 2 #diabetes had a reduced📉 risk for COPD hospitalization, noninvasive positive-pressure ventilation and all-cause mortality if they used an #SGLT-2 inhibitor. @EndocrineToday https://t.co/3RB5v2pdCi
-
-
Mashup Score: 5
Patients with COPD and type 2 diabetes had a reduced risk for COPD hospitalization, noninvasive positive-pressure ventilation and all-cause mortality if they used an SGLT-2 inhibitor, according to study results.These data were published in Annals of the American Thoracic Society.
Source: www.healio.comCategories: General Medicine News, PulmonologyTweet-
Published in @AnnalsATS: Patients with #COPD and type 2 #diabetes had a reduced📉 risk for COPD hospitalization, noninvasive positive-pressure ventilation and all-cause mortality if they used an #SGLT-2 inhibitor. @EndocrineToday https://t.co/3RB5v2pdCi
-
Published in @AnnalsATS: Patients with #COPD and type 2 #diabetes had a reduced📉 risk for COPD hospitalization, noninvasive positive-pressure ventilation and all-cause mortality if they used an #SGLT-2 inhibitor. @EndocrineToday https://t.co/3RB5v2pdCi